Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Review
Overview
Research
Additional Document Info
View All
Overview
publication date
January 1, 2022
webpage
Web of Science
published in
CANCER DRUG RESISTANCE
Journal
Research
keywords
EGFR/K-RAS/SIAH pathway activation in TNBC
Triple-negative breast cancer ( TNBC)
and treatment optimization
chemo-resistance
detection of chemo-resistance
neoadjuvant chemotherapy prognosis
patient risk stratification
precision quantification of therapy efficacy
seven in absentia (SINA) and human homologs of SINA ( SIAH) E3 ligase
ubiquitin-mediated proteolysis
Additional Document Info
start page
691
end page
702
volume
5
issue
3